XML 30 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2023
Stock-Based Compensation [Abstract]  
Schedule of Assumptions were used in the Fair-Value Method The weighted-average grant date fair value of options granted was $0.98 and $3.58 per share for the nine months ended December 31, 2023 and 2022, respectively, and $0.97 and $1.86 for the three months ended December 31, 2023 and 2022, respectively. The following assumptions were used in the fair-value method calculations:
   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2023   2022   2023   2022 
Risk-free interest rates   3.8% - 4.7%   3.93% - 3.99%   3.5% - 4.7%   2.82% - 4.06%
Volatility   123.4% - 127.6%   149%   82.5% - 152.2%   149% - 223%
Expected life (years)   5.0 – 5.4    5.0 – 5.7    5.0 – 6.2    5.0 – 5.7 
Schedule of Summarizes the Activity in the Shares The following table summarizes the activity in the shares available for grant under the Plan during the nine months ended December 31, 2023:
       Options Outstanding 
   Shares   Number   Weighted 
   Available   of   Average 
   for Grant   Shares   Exercise Prices 
Balance at March 31, 2023   2,132,292    2,481,090   $        5.19 
Options granted   (373,375)   373,375    1.27 
Share awards   (6,375)   
    
 
Options cancelled and returned to the Plan   30,272    (30,272)   4.29 
Balance at June 30, 2023   1,782,814    2,824,193    4.68 
Options granted   (101,875)   101,875    1.16 
Share awards   (6,265)   
    
 
RSUs granted   (250,000)   
    
 
Options cancelled and returned to the Plan   13,404    (13,404)   9.05 
Balance at September 30, 2023   1,438,078    2,912,664    4.54 
Options granted   (941,408)   941,408    1.11 
Share awards   (6,375)   
    
 
Options cancelled and returned to the Plan   155,679    (155,679)   3.77 
Balance at December 31, 2023   645,974    3,698,393   $3.70 

 

Schedule of RSU Activity under the Plan A summary of RSU activity under the Plan is presented below.
   Number   Weighted
Average
Grant-
 
   of
Shares
   Date
Fair Value
 
Balance at June 30, 2023   
   $
 
Granted   250,000   $0.91 
Vested   (20,834)  $0.91 
Non-vested shares at September 30, 2023   229,166   $0.91 
Vested   (20,834)  $0.91 
Non-vested shares at December 31, 2023   208,332   $0.91 
Schedule of Outstanding and Exercisable Options The following table summarizes the range of outstanding and exercisable options as of December 31, 2023:
   Options Outstanding   Options Exercisable 
Range of Exercise Price  Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in Years)
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
value
 
$0.93 - $2.00   2,246,118    8.55   $1.48    653,549   $1.83   $62,794 
$3.95 - $7.51   943,145    7.45   $5.29    734,459   $5.59    
 
$8.61 - $17.70   509,130    7.48   $10.53    448,562   $10.35    
 
$0.93 - $17.70   3,698,393    8.12   $3.70    1,836,570   $5.47   $62,794